Azeria Therapeutics competitorsClear all

Azeria Therapeutics's top competitors include Calidi Biotherapeutics and Immutep.
Discover new suppliers and conduct deeper comparison analysis with Craft for EnterpriseLearn more
Banner background
Azeria Therapeutics
Azeria Therapeutics
Azeria Therapeutics is a company that develops a cancer drug intended to aid in the treatment of breast and prostate cancer patients.
Calidi Biotherapeutics
Calidi Biotherapeutics
Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer.
Immutep
Immutep
Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.
Founding Date
Founding Date
2017
Founding Date
2014
Founding Date
2001
Type
Type
Private
Type
Private
Type
Public
Tags
Locations
Locations
Cambridge, GB HQ
Locations
San Diego, US HQ
Locations
Sydney, AU HQ
Sydney, AU
The Rocks, AU
Orsay, FR
Berlin, DE
Leipzig, DE
Employees
Employees
3
Employees
26
Employees
2427% decrease

Funding

Latest funding round
Latest funding round
$ 41.3m (over 2 years ago)
Latest funding round
$ 8.2m (over 2 years ago)
Latest funding round
N/A
Total funding raised
Total funding raised
$ 46.5m
Total funding raised
$ 20m
Total funding raised
N/A
For sources of this data, please see the company profile

View company profiles

Calidi Biotherapeutics
HQ
San Diego, US
Employees
26

Calidi Biotherapeutics is a company that specializes in oncolytic virus-based immunotherapies for cancer.

View company
Immutep
HQ
Sydney, AU
Employees
24↓ 27% decrease

Immutep (formerly Prima BioMed) is a biotechnology company focused on developing autoimmune and cancer immunotherapy treatment.

View company